account_id none on file
legal_name Neurocrine Biosciences Inc
ticker NBIX
cik 914475
domain neurocrine.com
linkedin_company_url https://www.linkedin.com/company/neurocrine/
entry_point_account_id none on file
name Neurocrine Biosciences Inc.
exchange Nasdaq
sector Health Care
hq San Diego, CA, United States
sector index/company/sector/health-care/
calls 0 filings 53 executives 0 family 0
why_nownone on file
callsnone on file
filings
In addition, the unaudited pro forma financial information is not a projection of future results of operations of the combined company nor does it reflect the expected realization of any synergies or cost savings associated with the acquisition.
filing / Jul 31, 2026 / receipt
Additionally, recent policy discussions have included potential targeted tariffs or other trade measures specifically aimed at pharmaceutical products and ingredients as part of broader healthcare cost control or national security initiatives.
filing / Jul 31, 2026 / receipt
Our operating leases that have commenced have terms that expire beginning 2027 through 2036 and consist of office space and research and development laboratories, including our corporate headquarters.
filing / Jul 31, 2026 / receipt
Our operating leases that have commenced have terms that expire beginning 2027 through 2036 and consist of office space and research and development laboratories, including our corporate headquarters.
filing / May 5, 2026 / receipt
The implementation of these cost containment measures may prevent us from being able to generate revenue, attain sustained profitability or commercialize our drugs, particularly since the majority of our current revenue is derived from federal healthcare programs, including Medicare and Medicaid.
filing / May 5, 2026 / receipt
Additionally, recent policy discussions have included potential targeted tariffs or other trade measures specifically aimed at pharmaceutical products and ingredients as part of broader healthcare cost control or national security initiatives.
filing / May 5, 2026 / receipt
Associate Director, Clinical Supply Chain | {"ats": "workday", "city": null, "state": null, "job_id": "/job/US-CA-San-Diego/Associate-Director--Clinical-Supply-Chain_R7247", "remote": false, "category
company_statement / Sep 15, 2026 / receipt
Sr. Specialist, Space Planning | {"ats": "workday", "city": null, "state": null, "job_id": "/job/US-CA-San-Diego/Sr-Specialist--Space-Planning_R7251-1", "remote": false, "category": "other", "function
company_statement / Sep 15, 2026 / receipt
Sr. Specialist, QA Operations | {"ats": "workday", "city": null, "state": null, "job_id": "/job/US-CA-San-Diego/Sr-Specialist-CQA_R7239", "remote": false, "category": "other", "function": "engineering
company_statement / Sep 15, 2026 / receipt
Federal Government Affairs Manager | {"ats": "workday", "city": null, "state": null, "job_id": "/job/US-DC-Office/Federal-Government-Affairs-Manager_R7245-1", "remote": false, "category": "other", "fu
company_statement / Sep 15, 2026 / receipt
2026 INGREZZA Net Sales and Expense Guidance Reaffirmed
ir_statement / Sep 15, 2026 / receipt
SG&A guidance range reflects expense for ongoing commercial initiatives supporting INGREZZA growth and the launch of CRENESSITY including expansion of sales teams.
ir_statement / Sep 15, 2026 / receipt
executivesnone on file
familynone on file
upcoming
changesnone on file
mcp_package_hint
slug neurocrine-biosciences-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$